Huntington`s Disease Therapeutics Market by Type (Disease-modifying Therapies, Gene Therapies, Medication), End-User (Hospitals, Long-Term Care Facilities, Specialty Clinics) - Global Forecast 2024-2030

Huntington`s Disease Therapeutics Market by Type (Disease-modifying Therapies, Gene Therapies, Medication), End-User (Hospitals, Long-Term Care Facilities, Specialty Clinics) - Global Forecast 2024-2030


The Huntington`s Disease Therapeutics Market size was estimated at USD 516.01 million in 2023 and expected to reach USD 597.43 million in 2024, at a CAGR 17.14% to reach USD 1,561.74 million by 2030.

Global Huntington`s Disease Therapeutics Market

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Huntington`s Disease Therapeutics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Huntington`s Disease Therapeutics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Huntington`s Disease Therapeutics Market, highlighting leading vendors and their innovative profiles. These include Alnylam Pharmaceuticals, Inc., Alterity Therapeutics Limited, Annexon Biosciences, AOP Orphan Pharmaceuticals GmbH, Bausch Health Companies Inc., Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals PLC, Ionis Pharmaceuticals Inc., Ipsen S.A., Lupin Limited, Medesis Pharma SA, Mitochon Pharmaceuticals, Inc., NeuExcell Therapeutics Inc, Neurocrine Biosciences, Inc., Novartis AG, Pfizer Inc., Prilenia Therapeutics B.V., PTC Therapeutics Inc., SOM Innovation Biotech S.A., Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd., uniQure N.V., Vaccinex Inc., and Vertex Pharmaceuticals Incorporated.

Market Segmentation & Coverage

This research report categorizes the Huntington`s Disease Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
Disease-modifying Therapies

Gene Therapies

Medication

Occupational Therapies

Symptomatic Treatment

End-User
Hospitals

Long-Term Care Facilities

Specialty Clinics

Region
Americas
Argentina

Brazil

Canada

Mexico

United States
California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas

Asia-Pacific
Australia

China

India

Indonesia

Japan

Malaysia

Philippines

Singapore

South Korea

Taiwan

Thailand

Vietnam

Europe, Middle East & Africa
Denmark

Egypt

Finland

France

Germany

Israel

Italy

Netherlands

Nigeria

Norway

Poland

Qatar

Russia

Saudi Arabia

South Africa

Spain

Sweden

Switzerland

Turkey

United Arab Emirates

United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Huntington`s Disease Therapeutics Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Huntington`s Disease Therapeutics Market?
3. What are the technology trends and regulatory frameworks in the Huntington`s Disease Therapeutics Market?
4. What is the market share of the leading vendors in the Huntington`s Disease Therapeutics Market?
5. Which modes and strategic moves are suitable for entering the Huntington`s Disease Therapeutics Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Huntington`s Disease Therapeutics Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increase in need for drugs to control Huntington's disease symptoms
5.1.1.2. Rising government initiatives to increase awareness about Huntington's disease
5.1.2. Restraints
5.1.2.1. High cost associated with advanced treatments
5.1.3. Opportunities
5.1.3.1. Increase in clinical research activities for drug development for Huntington's disease
5.1.3.2. Growing drug approvals for the treatment of Huntington's disease patients
5.1.4. Challenges
5.1.4.1. Problems associated with strict regulatory policies for development of Huntington's disease drugs
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Huntington`s Disease Therapeutics Market, by Type
6.1. Introduction
6.2. Disease-modifying Therapies
6.3. Gene Therapies
6.4. Medication
6.5. Occupational Therapies
6.6. Symptomatic Treatment
7. Huntington`s Disease Therapeutics Market, by End-User
7.1. Introduction
7.2. Hospitals
7.3. Long-Term Care Facilities
7.4. Specialty Clinics
8. Americas Huntington`s Disease Therapeutics Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Huntington`s Disease Therapeutics Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.
10. South Korea
9.
11. Taiwan
9.
12. Thailand
9.
13. Vietnam
10. Europe, Middle East & Africa Huntington`s Disease Therapeutics Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.
10. Nigeria
10.
11. Norway
10.
12. Poland
10.
13. Qatar
10.
14. Russia
10.
15. Saudi Arabia
10.
16. South Africa
10.
17. Spain
10.
18. Sweden
10.
19. Switzerland
10.
20. Turkey
10.
21. United Arab Emirates
10.
22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player
12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. Alnylam Pharmaceuticals, Inc.
12.1.2. Alterity Therapeutics Limited
12.1.3. Annexon Biosciences
12.1.4. AOP Orphan Pharmaceuticals GmbH
12.1.5. Bausch Health Companies Inc.
12.1.6. Dr. Reddy's Laboratories Ltd.
12.1.7. Hikma Pharmaceuticals PLC
12.1.8. Ionis Pharmaceuticals Inc.
12.1.9. Ipsen S.A.
12.1.
10. Lupin Limited
12.1.
11. Medesis Pharma SA
12.1.
12. Mitochon Pharmaceuticals, Inc.
12.1.
13. NeuExcell Therapeutics Inc
12.1.
14. Neurocrine Biosciences, Inc.
12.1.
15. Novartis AG
12.1.
16. Pfizer Inc.
12.1.
17. Prilenia Therapeutics B.V.
12.1.
18. PTC Therapeutics Inc.
12.1.
19. SOM Innovation Biotech S.A.
12.1.
20. Sun Pharmaceutical Industries Limited
12.1.
21. Teva Pharmaceutical Industries Ltd.
12.1.22. uniQure N.V.
12.1.
23. Vaccinex Inc.
12.1.
24. Vertex Pharmaceuticals Incorporated
12.2. Key Product Portfolio
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
FIGURE 1. HUNTINGTON`S DISEASE THERAPEUTICS MARKET RESEARCH PROCESS
FIGURE 2. HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, 2023 VS 2030
FIGURE 3. HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. HUNTINGTON`S DISEASE THERAPEUTICS MARKET DYNAMICS
FIGURE 7. HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 10. HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. HUNTINGTON`S DISEASE THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. HUNTINGTON`S DISEASE THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings